Tom Foltynie

68PUBLICATIONS
198CO-AUTHORS
Molecular targetsPredictive and prognostic markersNeurology and neuromuscular diseasesPharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|May 28, 2026
Observations on an Open-Label Phase 1/2 Dopamine Gene Therapy Trial (OXB-102/Axo-Lenti-PD) in People with Parkinson's Disease.

|May 07, 2026
Clinical prognostic indicators in multiple system atrophy.

|Mar 05, 2026
Peripheral and CSF protein quantification in Parkinson's disease and multiple system atrophy-the nucleic acid-linked immuno-sandwich assay.

Nirosen Vijiaratnam, Christine Girges, Arthur Mitchell

|Feb 09, 2026
Evolution of disease modifying therapy clinical trial design and therapeutic endpoints for Parkinson's disease.

Tom Foltynie, Sonia Gandhi, Camille Carroll

|Dec 25, 2025
A Multi-Symptom Circuit Architecture of Obsessive-Compulsive Disorder.

Barbara Hollunder, Garance M Meyer, Ningfei Li

|Oct 03, 2025
Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease.

Bahman Abdi-Sargezeh, Sepehr Shirani, Abhinav Sharma

Pageof 12

Frequent Collaborators

12 joint publications

Huw R Morris

11 joint publications

Ludvic Zrinzo

7 joint publications

Nirosen Vijiaratnam

6 joint publications

Caroline Helen Williams-Gray